Understanding and modulating cyclin-dependent kinase inhibitor specificity: molecular modeling and biochemical evaluation of pyrazolopyrimidinones as CDK2/cyclin A and CDK4/cyclin D1 inhibitors.
Karen A. RossiJay A. MarkwalderSteven P. SeitzChong-Hwan ChangSarah CoxMichael D. BoisclairLeonardo BrizuelaStephen L. BrennerPieter F. W. StoutenPublished in: J. Comput. Aided Mol. Des. (2005)